B12

DIETARY_SUPPLEMENT6 trials

Sponsors

Arkansas Children's Hospital Research Institute, Massachusetts General Hospital, Boehringer Ingelheim, Assiut University, Azienda Ospedaliera Universitaria Integrata Verona

Conditions

AgingAnemiaAutistic DisorderCarcinoma, Non-Small-Cell LungDiabete Type 2Healthspan ImprovementLongevitySchizophrenia

Phase 3

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

CompletedNCT00806819

Boehringer IngelheimCarcinoma, Non-Small-Cell Lung

Start: 2008-12-31End: 2015-12-31Updated: 2017-02-02

Combination Gerotherapeutic Interventions for Healthspan Improvement

Active, not recruitingNCT07475546

AgelessRxAging, Healthspan Improvement, Longevity

Start: 2025-07-23End: 2026-04-01Target: 30Updated: 2026-03-16

Phase 4

Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia

CompletedNCT00611806

Massachusetts General HospitalSchizophrenia

Start: 2007-12-31End: 2010-12-31Updated: 2014-08-19

Management of Preoperative Anaemia in Surgical Oncology

Azienda Ospedaliera Universitaria Integrata VeronaAnemia, Tumor

Start: 2021-03-02End: 2024-08-13Target: 500Updated: 2022-08-19

Unknown Phase

Treating Oxidative Stress and the Metabolic Pathology of Autism

CompletedNCT00572741

Arkansas Children's Hospital Research InstituteAutistic Disorder

Start: 2008-06-30End: 2016-04-30Updated: 2016-05-05

Vascular and Metabolic Changes in Postmenopausal Diabetics

Assiut UniversityDiabete Type 2

Start: 2018-10-02End: 2018-11-15Target: 100Updated: 2018-06-27

Related Papers

Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial.

2017-07-019 citations

Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia.

2013-05-0194 citations